PharmiWeb.com - Global Pharma News & Resources
04-Dec-2018

3D Printed Drugs Market, 2024 - ResearchAndMarkets.com

The "3D Printed Drugs Market" report has been added to ResearchAndMarkets.com's offering.

The 3D Printed Drugs market is anticipated to witness lucrative growth in the near future. The ease of ingestion of drug for the patients suffering from several diseases causing seizures such as epilepsy, medicinal intake by old age and infants are several applications of 3D printed drugs effecting the 3D Printed Drugs market in forth coming years.

Global 3D printed drugs market is segmented on the basis of application into orthopedic, neurology, hearing & audibility aid, medical implants, dental and others. Among these segments, Neurology segment (37.1% share in 2016) occupies the largest market of 3D printed drugs across the globe. Further, global Neurology segment is anticipated to reach USD 594.6 Million by the end of 2024 from USD 156.6 Million in 2016

FabRx Ltd. Technologies Inc., Aprecia Pharmaceuticals, LLC. are the only players of 3D printed drugs market and GlaxoSmithKline (GSK) is considered to be a potential player as the organization is contemplating to invest considerably in the industry.

Key Topics Covered:

1. Executive Summary

2. Research Methodology

3. Global 3D Printed Drugs Market Size (USD Million) and Forecast, 2017-2024

4. Market Dynamics & Its Impact Analysis

5. Global Market Segmentation Analysis

6. Porter's Five Force Model Analysis

7. Competitive Landscape

  • Apprecia Pharmaceuticals
  • FabRx Ltd
  • GlaxoSmithKline

For more information about this report visit https://www.researchandmarkets.com/research/wxm8k5/3d_printed_drugs?w=4

View source version on businesswire.com: https://www.businesswire.com/news/home/20181204005628/en/

Editor Details

Last Updated: 04-Dec-2018